R&D Frontiers
Early-Life Pancreas Development Offers Clues to More Aggressive Type 1 Diabetes in Young Children
2025-11-21
Precision Oncology in Focus at ESMO 2025: New Data Across Rare Cancers, CML, and Solid Tumors
2025-10-20
The Biologics Landscape Is Changing—Fast: CDMOs Race to Integrate Development, Scale, and Next-Gen Modalities
2025-10-20
Teaching the Immune System When to Say “Yes” or “No”: Nobel Laureate Dr. Shimon Sakaguchi’s Treg Discovery in Cancer, Autoimmunity, and Drug Development
2025-10-19
Japan’s 2025 Bioindustry Awards: From Alzheimer’s Treatments to Regenerative Medicine, the Nation Charts Its Next Biotech Course
2025-10-16
One Network, Many Nodes: How Japan’s Drug Discovery Hubs Can Compete Globally in the Next Decade
2025-10-15
Is Genmab’s New Asset the Next Big Bet in PD-1 Combination Therapy for Head and Neck Cancer?
2025-10-01
EGFR Lung Cancer 2025: AstraZeneca’s Tagrisso vs J&J’s Rybrevant in Global Trials Highlight Efficacy and Tolerability Trade-Offs
2025-09-30
Breakthrough in Breast Cancer for 2.3 Million Women: evERA Trial Delivers 70% ER Positive Insight with Giredestrant Combo
2025-09-25
Academia Sinica engineers first dual carbon-fixation plant system; “synthetic C2” boosts CO₂ capture, growth, and lipids
2025-09-23
LATEST
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
EVENT
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea



